DCOY NASDAQ
Decoy Therapeutics Inc.
1W: -42.7%
1M: -40.6%
3M: -75.6%
YTD: -77.4%
$1.77
-0.09 (-4.58%)
Weekly Expected Move ±24.8%
$1
$1
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
25 relationships25
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-01-13
Earliest Filing
2025-11-13
Latest Filing
target: 21
partner: 2
investor: 1
acquirer: 1
Counterparties (Filed by DCOY)
25 relationshipsCompanies named in DCOY's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Equiniti Trust Company, LLC | — | partner | Warrant agent for the Series A, Series B, and pre-funded warrants. | 2025-11-13 | View |
| Decoy Therapeutics MergerSub II, LLC | DCOY | target | Merger subsidiary entity involved in the merger agreement with Decoy Therapeutics. | 2025-11-13 | View |
| Decoy Therapeutics MergerSub I, Inc. | DCOY | target | Merger subsidiary entity involved in the merger agreement with Decoy Therapeutics. | 2025-11-13 | View |
| Decoy Therapeutics Inc. | DCOY | target | Target company in the merger agreement resulting in Decoy becoming a wholly owned subsidiary. | 2025-11-13 | View |
| Ladenburg Thalmann & Co. Inc. | — | partner | Sole underwriter for the public offering of common stock and warrants. | 2025-11-13 | View |
| Decoy Therapeutics Inc. | DCOY | target | Target company in the Merger Agreement with Salarius Pharmaceuticals, Inc. | 2025-09-18 | View |
| Decoy Therapeutics MergerSub I, Inc. | DCOY | target | Merger subsidiary of Decoy Therapeutics involved in the Merger Agreement. | 2025-09-18 | View |
| Decoy Therapeutics MergerSub II, LLC | DCOY | target | Merger subsidiary of Decoy Therapeutics involved in the Merger Agreement. | 2025-09-18 | View |
| Decoy Therapeutics Inc. | DCOY | target | Target of the Merger Agreement with Salarius Pharmaceuticals, Inc. | 2025-07-29 | View |
| Decoy Therapeutics MergerSub I, Inc. | DCOY | target | MergerSub entity party to the Merger Agreement with Salarius Pharmaceuticals, Inc. | 2025-07-29 | View |
| Decoy Therapeutics MergerSub II, LLC | DCOY | target | MergerSub entity party to the Merger Agreement with Salarius Pharmaceuticals, Inc. | 2025-07-29 | View |
| Decoy Therapeutics Inc. | DCOY | target | Target company in the merger agreement with Salarius Pharmaceuticals, Inc. | 2025-07-21 | View |
| Decoy Therapeutics MergerSub I, Inc. | DCOY | target | Merger subsidiary of Decoy Therapeutics Inc. involved in the merger agreement. | 2025-07-21 | View |
| Decoy Therapeutics MergerSub II, LLC | DCOY | target | Merger subsidiary of Decoy Therapeutics Inc. involved in the merger agreement. | 2025-07-21 | View |
| Decoy Therapeutics Inc. | DCOY | target | Target company in a merger agreement with Salarius Pharmaceuticals, Inc. | 2025-06-11 | View |
| Decoy Therapeutics MergerSub II, LLC | DCOY | target | Wholly owned subsidiary of Salarius Pharmaceuticals, Inc. involved in the merger. | 2025-06-11 | View |
| Decoy Therapeutics MergerSub I, Inc. | DCOY | target | Wholly owned subsidiary of Salarius Pharmaceuticals, Inc. involved in the merger. | 2025-06-11 | View |
| Decoy Therapeutics MergerSub II, LLC | DCOY | target | Wholly owned subsidiary of Salarius Pharmaceuticals, Inc. entering the merger agreement. | 2025-03-28 | View |
| Decoy Therapeutics MergerSub I, Inc. | DCOY | target | Wholly owned subsidiary of Salarius Pharmaceuticals, Inc. entering the merger agreement. | 2025-03-28 | View |
| Decoy Therapeutics Inc. | DCOY | target | Target company in the proposed merger agreement with Salarius Pharmaceuticals, Inc. | 2025-03-28 | View |
| Decoy Therapeutics Inc. | DCOY | target | Target company in a stock-for-stock merger agreement with Salarius Pharmaceuticals, Inc. | 2025-01-13 | View |
| Decoy Therapeutics MergerSub I, Inc. | DCOY | target | Wholly owned subsidiary of Salarius Pharmaceuticals, Inc. used as the surviving entity in the first merger step. | 2025-01-13 | View |
| Decoy Therapeutics MergerSub II, LLC | DCOY | target | Wholly owned subsidiary of Salarius Pharmaceuticals, Inc. used as the surviving entity in the second merger step. | 2025-01-13 | View |
| C/M Capital Master Fund, LP | — | investor | Purchased up to $10 million of Salarius Pharmaceuticals' common stock under a securities purchase agreement. | 2024-12-13 | View |
| DeuteRx, LLC | — | acquirer | Acquired assets including DRX-164 and intellectual property from Salarius Pharmaceuticals, Inc. | 2022-01-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-23 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-09-15 | Shareholder Vote | View | |
| 2026-07-15 | Shareholder Vote | View | |
| 2026-06-29 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-05-19 | Other Events | View | |
| 2026-04-02 | Other Events; Exhibits | View | |
| 2026-03-05 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2026-02-25 | Submission of Matters to a Vote of Security Holders | View | |
| 2026-01-08 | Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits | View | |
| 2026-01-02 | Submission of Matters to a Vote of Security Holders | View | |
| 2026-01-02 | Notice of Delisting or Transfer | View | |
| 2025-12-19 | Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Financial Statements | View | |
| 2025-11-19 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-17 | Regulation FD Disclosure | View | |
| 2025-11-13 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi | Agreement Acquisition | View |
| 2025-10-21 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-14 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-06 | Other Events | View | |
| 2025-09-18 | Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Finan | Agreement | View |
| 2025-09-09 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR